Scailyte AG Revenue and Competitors
Estimated Revenue & Valuation
- Scailyte AG's estimated annual revenue is currently $4.8M per year.
- Scailyte AG's estimated revenue per employee is $155,000
Employee Data
- Scailyte AG has 31 Employees.
- Scailyte AG grew their employee count by 0% last year.
Scailyte AG's People
Name | Title | Email/Phone |
---|
Scailyte AG Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Scailyte AG?
True precision medicine through single-cell science. Scailyte is an ETH Zirich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into diseases and enables ultra-sensitive diagnostics by uncovering human's hidden "single-cell" secrets. The performance and clinically-relevant application of Scailyte's platform ScaiVision have been demonstrated in numerous clinical projects that resulted in patent-pending biomarkers. Scailyte has a growing pipeline of clinical projects in immunology, oncology and women's health supported by top clinicians and access to high quality proprietary datasets. If you want to partner with us and save lives by enabling precision medicine, reach out to contact@scailyte.com More information about our company, technology & services you can find on our website - https://scailyte.com
keywords:N/AN/A
Total Funding
31
Number of Employees
$4.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Scailyte AG News
Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis. Press Release - Apr 11, 2022 16:00...
InfanDx AG announces that it has set up US operations to gain access to the ... Scailyte and Sirona DX announce a strategic partnership to...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.5M | 31 | 63% | N/A |
#2 | N/A | 32 | 7% | N/A |
#3 | $3.3M | 32 | 3% | N/A |
#4 | $5.1M | 33 | -13% | N/A |
#5 | $5.1M | 33 | 38% | N/A |